Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 111

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4A
Chunk 111
---
,577 thousand in 2024 and 2023, respectively;  
  and                                                                                                                 
  Net operating cash outflows of approximately $19,700 thousand and $21,577 thousand in 2024 and 2023, respectively;  
  and                                                                                                                 
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Our accumulated deficit balance as of December 31, 2024, was approximately $274,071 thousand.  

We have approved a plan to improve our available cash balances,
liquidity and cash flows generated from operations. We have identified several potential actions including cost preservation measures
that would be initiated in a timely manner to address our liquidity needs over the twelve-month period from the date this Annual report,
as follows:

  Reducing non-essential expenses and implement headcount reductions to conserve cash  

  Deferral and reprioritization of certain research and development programs that would  

We have a history of operating losses and negative cash flows from
operations. However, despite these conditions, we believe management’s plans, as described more fully above, will provide sufficient
liquidity to meet our financial obligations and maintain levels of liquidity over the twelve-month period from the date of this Annual
Report. Therefore, management concluded this plan alleviates the substantial doubt that was raised about our ability to continue as a
going concern for at least twelve months from the date this Annual Report.

Although not considered for purposes of our assessment of whether
substantial doubt was alleviated, we have plans to improve operating cash flows by entering other collaborations, strategic alliances
or licensing arrangements with third parties. We are also exploring exit opportunities for certain subsidiaries. We may seek to raise
additional funds through public or private equity or debt financings or other sources.

Our plans are subject to inherent risks and uncertainties. Accordingly,
there can be no assurance that our plans can be effectively implemented and, therefore, that the conditions can be effectively mitigated.

Until such time, if ever, we expect to finance our operations through
equity or debt financings, which may not be available to us on the timing needed or on terms that we deem to be favorable. To the extent
that we raise additional capital through the sale of equity or debt securities, the ownership interest of our shareholders will be diluted.
If we are unable to maintain sufficient financial resources, our business, financial condition and results of operations will be materially
and adversely affected.

Cash Flows

The following table presents the major components of net cash